Albert Reese IV
Story Poster
'Operation Blackout' commences as No. 6 Aggies strive for a 5-0 record
1 mo ago by Olin Buchanan
The pressure is on as the Aggies, who are 3-1 in black uniforms and 4-0 for the first time since 2016, go dark against Mississippi State on Saturday night. After a strong defensive showing against Auburn, Mike Elko & Co. will face a different type of test from Jeff Lebby's Bulldogs.
Story Poster
Key Matchups: No. 6 Texas A&M vs. Mississippi State
1 mo ago by Olin Buchanan
At 4-0 overall and 1-0 in conference play, No. 6 Texas A&M faces Mississippi State at Kyle Field in a contest that has been dubbed "Operation Blackout" in Aggieland. Ahead of Saturday's contest, Olin Buchanan details the in-game matchups that will have the greatest impact on the outcome.
Story Poster
7:41
Nuño's Notes: Starkville storylines as Lebby & Co. come to Aggieland
1 mo ago by David Nuño
Before No. 6 Texas A&M trades its Maroon for black on Saturday night, David Nuño spoke to a handful of Mississippi State insiders to get a feel for where Jeff Lebby's upstart Bulldogs currently stand as they come to Aggieland for a Week 6 matchup in the SEC.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
Tale of the Tape: No. 6 Texas A&M vs. Mississippi State
1 mo ago by TexAgs
Jeff Lebby slumped to a 2-10 finish in his first season at Mississippi State, but the Bulldogs have already doubled that win total through their first five games of 2025. Saturday night will see No. 6 Texas A&M paint Kyle Field black for another Southeastern Conference showdown.
Story Poster
296:37
SECMD24: Day 3 features Alabama, Mississippi State, Florida & Texas
1 yr ago by TexAgs
Wednesday at SEC Media Days brings representatives from Alabama, Mississippi State, Florida and Texas to the spotlight. Each head coach and three player representatives for each school took to the stage on Day 3 in Dallas.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.